By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xencor 

111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery





Company News
Xencor Presents Interim Data From An Ongoing, Open-Label, Phase II Study of XmAb5871 In Igg4-Related Disease At EULAR 2017 6/16/2017 6:35:53 AM
Xencor Appoints Raphael Clynes, M.D., Ph.D., As Vice President Of Translational Biology 6/8/2017 7:14:41 AM
Xencor's Lead Drug Candidate, Xmab5871, Receives Orphan Drug Designation From FDA For Treatment Of Igg4-Related Disease 5/11/2017 7:22:37 AM
Xencor Reports First Quarter 2017 Financial Results 5/10/2017 10:49:29 AM
Xencor To Host First Quarter 2017 Financial Results Webcast And Conference Call On May 9, 2017 5/2/2017 10:43:52 AM
Xencor Appoints Kevin Gorman, Ph.D., To Its Board Of Directors 4/17/2017 6:54:49 AM
Xencor Reports Fourth Quarter And Full Year 2016 Financial Results 3/1/2017 9:56:17 AM
Xencor To Host Fourth Quarter And Full Year 2016 Financial Results Webcast And Conference Call On February 28, 2017 2/22/2017 11:10:07 AM
Xencor Release: Igg4-Related Disease Biomarker Development Update Presented From An Ongoing, Open-Label, Phase II Study Of Xmab5871 In Igg4-RD At The 3rd International Symposium On Igg4-Related Diseases & Fibrosis 2/20/2017 6:11:43 AM
Xencor Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 12/7/2016 6:47:09 AM
12345678910...
//-->